Principal results of the cancer of the ovary abiraterone trial (CORAL): A phase II study of abiraterone in patients with recurrent epithelial ovarian cancer (CRUKE/12/052)
2009 ◽
Vol 113
(2)
◽
pp. 205-209
◽
2010 ◽
Vol 118
(3)
◽
pp. 308-312
◽
2001 ◽
Vol 12
(8)
◽
pp. 647-652
◽
2009 ◽
Vol 16
(4)
◽
pp. 993-1000
◽
2015 ◽
Vol 137
(2)
◽
pp. 216-222
◽
2003 ◽
Vol 13
(Suppl 1)
◽
pp. 14.2-14